Capitalised terms used in this addendum have the meaning given in the Notice, unless the context otherwise requires.
The purpose of this addendum is to provide supplementary information for the purposes of 'Resolution 5 - Proposed issue of the Series 2 Convertible Notes and Series 3 Convertible Notes to
As set out on page 32 of the Notice, the Company noted the following with respect to Resolution 5: 'the proposed issue of the Series 2 Convertible Notes and the Series 3 Convertible Notes will occur no later than 3 months after the date of the Meeting, subject to the receipt of any waiver from ASX (which the Company has applied for at the date of this Notice)'.
The Company has now been granted a waiver from Listing Rule 7.3.4 (Waiver) to permit the Company not to state in the Notice that the Series 2 Convertible Notes and Series 3 Convertible Notes will be issued within 3 months of the date of the Meeting, provided certain conditions are met. Accordingly, the note outlined above with respect to Resolution 5 can effectively be removed from the Notice.
In compliance with the conditions of the Waiver, the Company advises that the Waiver has been issued on the following conditions: the Series 2 Convertible Notes are issued no later than
The Notice contains the required details regarding dilutionary effect and conversion, and the terms and conditions of the Convertible Notes agreements, so no amendments to the Notice are required, other than the removal of the note with respect to Resolution 5 mentioned above and the inclusion of the above Waiver conditions. There are no required amendments to the proxy form which shareholders have already received in relation to the Notice.
If Shareholders wish to vote on the Resolutions by proxy, they should follow the voting instructions set out on page 6 of the Notice and return their proxy form by
If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisors prior to voting. Should you wish to discuss the matters set out in the Notice as supplemented by this addendum, please contact the Company in accordance with the details set out in the Notice.
This announcement has been authorised for release by the Board of
Contact:
Tel: +61 416 079 329
Email: rebecca.thompson@bciminerals.com.au
(C) 2021 Electronic News Publishing, source